Sands Capital Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,138,777
| Closed | -$363M | – | 68 |
|
|
2017
Q4 | $363M | Sell |
1,138,777
-68,395
| -6% | -$21.8M | 1.1% | 29 |
|
|
2017
Q3 | $378M | Sell |
1,207,172
-70,991
| -6% | -$22.2M | 1.13% | 31 |
|
|
2017
Q2 | $347M | Sell |
1,278,163
-1,197,774
| -48% | -$325M | 1.04% | 29 |
|
|
2017
Q1 | $677M | Sell |
2,475,937
-102,972
| -4% | -$28.2M | 2.13% | 17 |
|
|
2016
Q4 | $731M | Sell |
2,578,909
-210,357
| -8% | -$59.7M | 2.55% | 16 |
|
|
2016
Q3 | $873M | Sell |
2,789,266
-180,964
| -6% | -$56.6M | 2.57% | 16 |
|
|
2016
Q2 | $718M | Sell |
2,970,230
-170,879
| -5% | -$41.3M | 2.22% | 19 |
|
|
2016
Q1 | $818M | Sell |
3,141,109
-226,422
| -7% | -$58.9M | 2.42% | 17 |
|
|
2015
Q4 | $1.03B | Sell |
3,367,531
-753,869
| -18% | -$231M | 2.66% | 16 |
|
|
2015
Q3 | $1.2B | Sell |
4,121,400
-611,545
| -13% | -$178M | 3.36% | 10 |
|
|
2015
Q2 | $1.91B | Sell |
4,732,945
-276,670
| -6% | -$112M | 4.7% | 5 |
|
|
2015
Q1 | $2.12B | Buy |
5,009,615
+35,284
| +0.7% | +$14.9M | 5.03% | 6 |
|
|
2014
Q4 | $1.69B | Buy |
4,974,331
+22,235
| +0.4% | +$7.55M | 4.02% | 8 |
|
|
2014
Q3 | $1.64B | Buy |
4,952,096
+60,633
| +1% | +$20.1M | 4.07% | 7 |
|
|
2014
Q2 | $1.54B | Buy |
4,891,463
+18,446
| +0.4% | +$5.82M | 3.89% | 9 |
|
|
2014
Q1 | $1.49B | Buy |
4,873,017
+118,857
| +3% | +$36.4M | 3.88% | 9 |
|
|
2013
Q4 | $1.33B | Buy |
4,754,160
+118,919
| +3% | +$33.2M | 3.47% | 10 |
|
|
2013
Q3 | $1.12B | Buy |
4,635,241
+69,320
| +2% | +$16.7M | 3.11% | 13 |
|
|
2013
Q2 | $983M | Buy |
+4,565,921
| New | +$983M | 3.31% | 11 |
|